dasatinib teva 70mg - otsingu tulemused

dasatinib teva õhukese polümeerikattega tablett

teva b.v. - dasatiniib - õhukese polümeerikattega tablett - 50mg 30tk; 50mg 60tk; 50mg 56tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatiniib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastilised ained - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Euroopa Liit - eesti - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatiniib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastilised ained - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Eesti - eesti - Ravimiamet

dasatinib norameda õhukese polümeerikattega tablett

norameda uab - dasatiniib - õhukese polümeerikattega tablett - 70mg 60tk

Eesti - eesti - Ravimiamet